Insulet
PODD
#2099
Rank
C$13.38 B
Marketcap
C$192.98
Share price
0.60%
Change (1 day)
-56.37%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): C$0.77 Billion

According to Insulet's latest financial reports the company's current earnings are C$3.05 Billion. In 2025 the company made an earning of C$0.56 Billion, an increase over its 2024 earnings that were of C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.77 B35.39%
2025 C$0.56 B16.3%
2024 C$0.48 B36.76%
2023 C$0.35 B481.9%
2022 C$61.48 M-45.24%
2021 C$0.11 B43.35%
2020 C$78.31 M18.51%
2019 C$66.08 M41.16%
2018 C$46.81 M-711.95%
2017 -C$7.66 Million-56.85%
2016 -C$17.74 Million-79.31%
2015 -C$85.72 Million63.85%
2014 -C$52.32 Million31.04%
2013 -C$39.93 Million-21.96%
2012 -C$51.16 Million
2010 -C$48.79 Million-42.38%
2009 -C$84.68 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$76.81 Million209.75%
2006 -C$24.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.38 B 4,635.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.60 B 1,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$10.45 B 1,224.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$47.92 B 5,970.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$87.02 Million-111.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.11 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.84 B 134.01%๐Ÿ‡บ๐Ÿ‡ธ USA